Fecula Biotech Co., Ltd.
Update：2025/12/03
Industries
Main Industry
Health Care
Founded Year
2019
Unified Business No.
42932624
Status
Active
Number of Employees
7
Total Paid-in
Capital
45,035,695 (NT$)
Location of Company
Taiwan
, Tainan City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
We focuses on the development and reuse of agricultural and fishery waste, integrating the concepts of sustainability and circular economy. By leveraging biotechnology, we achieve a synergistic effect where 1+1 > 2.
In the context of surplus banana production, We utilizes biotechnology to develop resistant starch from bananas into a dual-layer encapsulation technology for probiotics. This innovation enhances the viability of beneficial bacteria and allows them to survive longer in the digestive tract.
In the context of surplus banana production, we utilize biotechnology to develop resistant starch from bananas into a dual-layer encapsulation technology for probiotics. This innovation enhances the viability of beneficial bacteria and allows them to survive longer in the digestive tract. efficient colonization. Additionally, resistant starch promotes the growth of beneficial bacteria in the digestive system, offering greater health advantages!
In the context of surplus banana production, We utilizes biotechnology to develop resistant starch from bananas into a dual-layer encapsulation technology for probiotics. This innovation enhances the viability of beneficial bacteria and allows them to survive longer in the digestive tract.
In the context of surplus banana production, we utilize biotechnology to develop resistant starch from bananas into a dual-layer encapsulation technology for probiotics. This innovation enhances the viability of beneficial bacteria and allows them to survive longer in the digestive tract. efficient colonization. Additionally, resistant starch promotes the growth of beneficial bacteria in the digestive system, offering greater health advantages!
Corporate Video
